Clinical Trial Update: Effect of Montelukast Therapy on Clinical Course, Pulmonary Function, and Mortality in Patients With COVID-19 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating montelukast therapy effects on clinical course, pulmonary function, and mortality in COVID-19 pneumonia patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Bugra Kerget | Conditions: COVID-19 Pneumonia | Phase 4 | Status: UNKNOWN